Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cell lines with either no treatment or ANP32B knockdown

ABSTRACT: Cell lines with either no treatment or ANP32B knockdown

PROVIDER: PRJNA1015158 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25939375_1.fastq.gz	Fastqsanger.gz
	SRR25939375_2.fastq.gz	Fastqsanger.gz
	SRR25939376_1.fastq.gz	Fastqsanger.gz
	SRR25939376_2.fastq.gz	Fastqsanger.gz
	SRR25939377_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 29

Similar Datasets

CUT-TAG for AML cell lines with either no treatment or ANP32B knockdown

Project description:CUT-TAG for AML cell lines with either no treatment or ANP32B knockdown

| PRJNA1013815 | ENA

ANP32B-deficiency suppresses ocular development by repression of PAX6

Project description:We observed that the deletion of Anp32b led to severe defects in ocular development, such as anophthalmia and microphthalmia. Moreover, Anp32b was highly expressed in the lens, and Anp32b−/− embryos with microphthalmia typically exhibited severely impaired lens development. Mechanistically, ANP32B directly interacted with paired box protein 6 (PAX6), a master transcriptional regulator of ocular development, and enhanced its transcriptional activity. In line with these findings, overexpression of PAX6 partially but significantly reversed the inhibition of proliferation observed in ANP32B knockdown cells. Collectively, our findings reveal that ANP32B-deficiency suppresses ocular development by repression of PAX6 and identify ANP32B as a viable therapeutic target for ocular developmental defects.

2025-06-02 | GSE269101 | GEO

TET1 knockdown cancer cell lines

Project description:TET1 knockdown cancer cell lines

| PRJNA498002 | ENA

CUT-TAG for AML cell lines with either no treatment or ANP32B knockdown

Project description:Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are to explore CUT-TAG results for H3K27ac in AML cell lines.

2023-09-12 | GSE242532 | GEO

ANP32B-mediated repression of p53 contributes to maintenance of normal and CML stem cells

Project description:we demonstrate that conditional deletion of acidic leucine-rich nuclear phosphoprotein 32B (ANP32B) in hematopoietic cells impairs repopulation capacity and postinjury regeneration of HSCs. Mechanistically, ANP32B forms a repressive complex with and thus inhibits the transcriptional activity of p53 in hematopoietic cells, and p53 deletion rescues the functional defect in Anp32b-deficient HSCs. Of great interest, ANP32B is highly expressed in leukemic cells from patients with chronic myelogenous leukemia (CML). Anp32b deletion enhances p53 transcriptional activity to impair LSC function in a murine CML model and exhibits synergistic therapeutic effects with tyrosine kinase inhibitors in inhibiting CML propagation. In summary, our findings provide a novel strategy to enhance p53 activity in LSCs by inhibiting ANP32B and identify ANP32B as a potential therapeutic target in treating CML.

2021-09-27 | GSE184474 | GEO

SAM treatment of CRC cell lines

Project description:SAM treatment of CRC cell lines

| PRJNA640675 | ENA

Cell lines with either no treatment or ANP32B knockdown

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-09-12 | GSE242850 | GEO

Gene expression data from HepG2 SND1 knockdown stable cell lines after 5-Fu treatment

Project description:Gene expression data from HepG2 SND1 knockdown stable cell lines after 5-Fu treatment

| PRJNA471413 | ENA

DIA proteomics analysis of RNF223 knockdown and control pancreatic cancer cell lines

Project description:The proteome profiles of RNF223 knockdown and control pancreatic cancer cell lines were compared employing data independent acquisition(DIA) technology

2021-09-10 | PXD028446 |

CD73 knockdown effect in pancreatic cancer cell lines

Project description:CD73 knockdown effect in pancreatic cancer cell lines

| PRJNA480855 | ENA